secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001193125-24-018715
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology completes IPO of 23M shares at $19.00, raising $437M gross
----------------------------------------------------------------------

- IPO closed on Jan 29, 2024: 23M shares (includes full exercise of underwriters' option for 3M additional shares) at $19.00/share.
- Gross proceeds of $437.0 million before underwriting discounts and expenses.
- Charter amended: authorized common stock increased to 700M shares; 70M shares of undesignated preferred stock authorized.
- Charter establishes classified board with staggered three-year terms and limits stockholder actions by written consent.
- Exclusive forum provisions for Securities Act claims in federal courts and Delaware Chancery for other claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000119312524018715/0001193125-24-018715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000119312524018715/d114617d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-018715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer